ReviewAbdominal radiology (New York)2026
Focal "Targetoid" liver lesions on MRI: a diagnostic and practical imaging approach.
Review in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Targetoid liver lesions exhibit a characteristic MRI appearance, with differential signal intensity and enhancement between the central and peripheral components. This imaging pattern is observed across a wide range of benign, malignant, infectious, inflammatory, and vascular conditions. This educational pictorial essay aims to familiarize radiologists with the MRI spectrum of targetoid hepatic lesions and to introduce a practical diagnostic algorithm that integrates imaging findings with clinical context, thereby enhancing diagnostic accuracy in complex cases. MRI protocols include dynamic multiphase contrast-enhanced imaging with extracellular or hepatobiliary contrast agents, along with T2-weighted and diffusion-weighted sequences. Key imaging features, such as rim arterial-phase enhancement, delayed central enhancement, T2 target appearance, Targetoid appearence in diffusion restriction, and Targetoid appearance in the Transitional phase or Hepatobiliary phase with hepatobiliary contrast agents, are highlighted. By employing this structured approach, radiologists can interpret targetoid liver lesions with greater confidence and systematic precision, thereby supporting timely diagnosis and appropriate patient management.
Indexed as
Identifiers
41801375What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.